Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway. | Front Mol Neurosci | 2022 | 36187352 | PubTator, text mining | PubMed |
| Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation. | World Allergy Organ J | 2022 | 36185551 | PubTator, text mining | PubMed |
| Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent Inflammation. | Adv Sci (Weinh) | 2022 | 36180407 | PubTator, text mining | PubMed |
| Association of low-grade inflammation caused by gut microbiota disturbances with osteoarthritis: A systematic review. | Front Vet Sci | 2022 | 36172610 | PubTator, text mining | PubMed |
| Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein. | Front Immunol | 2022 | 36172386 | PubTator, text mining | PubMed |
| Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial Cells. | J Immunol | 2022 | 36165200 | PubTator, text mining | PubMed |
| Negative Cross-Talk between TLR2/4-Independent AMPKα1 and TLR2/4-Dependent JNK Regulates S. pneumoniae-Induced Mucosal Innate Immune Response. | J Immunol | 2022 | 36165197 | PubTator, text mining | PubMed |
| The interaction of MD-2 with small molecules in huanglian jiedu decoction play a critical role in the treatment of sepsis. | Front Pharmacol | 2022 | 36160407 | PubTator, text mining | PubMed |
| The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases. | Mol Aspects Med | 2022 | 36152458 | PubTator, text mining | PubMed |
| Unravelling the Therapeutic Potential of Nano-Delivered Functional Foods in Chronic Respiratory Diseases. | Nutrients | 2022 | 36145202 | PubTator, text mining | PubMed |
| Effects of Genistein on Common Kidney Diseases. | Nutrients | 2022 | 36145144 | PubTator, text mining | PubMed |
| Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: Computational and Experimental Approaches. | Int J Mol Sci | 2022 | 36142893 | PubTator, text mining | PubMed |
| Natural Xylooligosaccharides Exert Antitumor Activity via Modulation of Cellular Antioxidant State and TLR4. | Int J Mol Sci | 2022 | 36142342 | PubTator, text mining | PubMed |
| Small Molecules as Toll-like Receptor 4 Modulators Drug and In-House Computational Repurposing. | Biomedicines | 2022 | 36140427 | PubTator, text mining | PubMed |
| Computational Insights into the Sequence-Activity Relationships of the NGF(1-14) Peptide by Molecular Dynamics Simulations. | Cells | 2022 | 36139382 | PubTator, text mining | PubMed |
| Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis. | JCI Insight | 2022 | 36136452 | PubTator, text mining | PubMed |
| Identification of Inflammatory Proteomics Networks of Toll-like Receptor 4 through Immunoprecipitation-Based Chemical Cross-Linking Proteomics. | Proteomes | 2022 | 36136309 | PubTator, text mining | PubMed |
| Innate Immunity Mechanisms in Marine Multicellular Organisms. | Mar Drugs | 2022 | 36135738 | PubTator, text mining | PubMed |
| Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention. | Curr Oncol | 2022 | 36135048 | PubTator, text mining | PubMed |
| Effect of tricyclic 1,2-thiazine derivatives in neuroinflammation induced by preincubation with lipopolysaccharide or coculturing with microglia-like cells. | Pharmacol Rep | 2022 | 36129673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=40